Fitbit’s new glucose tracking feature allows users to log blood glucose meter data alongside activity, sleep, food, and more in the Fitbit app. Learn how your daily...

Professor Simon Heller is known globally for his renowned research on hypoglycemia; hear his opinion on using Time in Range in diabetes management

Dive into AGP if you haven’t already! In our third video on understanding your ambulatory glucose profile (AGP) report, Dr. Carlson from the International Diabetes...

Though A1C has long been used as the primary metric for evaluating someone’s estimated average blood sugar, the glucose management indicator (GMI) is an alternative that...

The Association of Diabetes Care and Education Specialists' 2020 conference covered how to use CGM to adjust insulin during exercise, how to reduce fear of hypoglycemia...

Tandem’s Control-IQ hybrid closed loop system will soon become the first automated delivery system available to people with type 1 diabetes in Canada

Dr. Francine Kaufman breaks down what we need to know about avoiding hypoglycemia and hyperglycemia during and after exercise. She explains the recommendations and...

What is an ambulatory glucose profile (AGP) report and what can it tell you? In this video, Dr. Rich Bergenstal from the International Diabetes Center explains the...

Average A1C values differ between racial and ethnic groups – people of color have a higher average A1C compared to white people. This is because someone’s A1C value...

Emerging evidence shows that variability in your A1C level may put you at a higher risk of stroke and heart disease.

Two studies recently published on the Control-IQ and MiniMed 780G systems show that closed-loop automated insulin delivery significantly improves Time in Range.

Two diabetes devices from Medtronic – a next-gen continuous glucose monitor that removes fingerstick calibrations and a smart insulin delivery pen that keeps track of...

Research shows that changes in Time in Range (TIR) affect your mood and that continuous glucose monitoring may help people with diabetes achieve better emotional health.

Time in Range (TIR) is another number for people with diabetes to pay attention to and use to improve their daily diabetes management. We talked with three women in the...

This clinical trial is currently recruiting. Families will participate in weekly sessions that focus on topics related to diabetes distress and parent-teen communication...

Four people from the diabetes community share insights on how and why they use Time in Range in their diabetes management, why it’s so different from relying only on A1C...

COVID-19 vaccines are being distributed in the United States and in many parts of the world. We’re here to answer questions for people with diabetes. Are the vaccines...

Full results from the SURPASS trials on the drug tirzepatide shows that this new medication dramatically lowers A1C and weight and is incredibly effective in people with...

The American Diabetes Association's 81st Scientific Sessions brought together great minds in diabetes for exciting news and discussions. Check out highlights from the...

The American Diabetes Association’s 81st Scientific Sessions is going strong. Updates from days two and three include promising Omnipod 5 results, Medtronic’s seven-day...